Exela Pharma Sciences is pulling three medications, including one Civica brand, because silicone was found in samples during routine inspection, the FDA said Oct. 25. 

The risk of a stroke was more prevalent for older adults who received a flu and bivalent COVID-19 vaccine within six weeks of the other in fall 2022, according to a preprint of research conducted by the FDA and CMS. 

Monthslong drug shortages have affected quality in surgery, emergency care and other hospital departments in 2023, according to a recent survey of 200 healthcare workers. Recently, eight more medications have fallen into short supply or discontinuation. 

A three-hospital system in Oswego, N.Y., filled its pharmacy director position with Sarah Driscoll, PharmD, who has been in the role in an interim capacity since June. 

Sen. Bernie Sanders, I-Vt., is urging HHS to investigate the National Institutes of Health's proposal to grant an exclusive patent to a cancer drug that NIH invented, manufactured and tested. 

Lexington, Ky.-based Appalachian Regional Healthcare has promoted Colby Newsome, PharmD, to director of its Behavioral Health Pharmacy.

Since launching in 2018, hospital-owned Civica Rx works with about a third of the nation's hospitals and manufactures 80 drugs facing shortages, NBC affiliate KSL-TV reported Oct. 22. 

The FDA is reviewing a nasal spray that could be the first self-administered flu vaccine if approved.

As the U.S. anticipates an increase in knee and hip replacement surgeries, adding a second antibiotic does not help prevent postoperative infections and can even spur adverse events, according to a recent study.

Pharmacies are disappearing across the country as retail chains cull hundreds of locations, and the closures are disproportionately affecting vulnerable populations, The Washington Post reported Oct. 22.

The FDA granted full-approval to Pfizer's meningococcal disease immunization, Penbraya, on Oct. 20. 

Mark Cuban's Cost Plus Drug. Co. is teaming up with Birmingham (Ala.) Apothecary to offer Team Cuban Cards beginning Nov. 1, Bham Now reported Oct. 20. 

Roche has agreed to acquire Telavant Holdings — the maker of an inflammatory bowel disease drug — from Roivant Sciences and Pfizer for $7.25 billion, the Switzerland-based company said in an Oct. 23 news release. 

By the end of the year, THC products will be available for purchase in some Georgia pharmacies, CNN reported Oct. 20. 

Biotech companies and drugmakers are shelving their AI-designed therapeutics after a series of clinical setbacks, Endpoints News reported Oct. 19. 

For the first time, an experimental antiviral for dengue virus showed efficacy in humans, Johnson & Johnson said Oct. 20. 

Eli Lilly and Novo Nordisk are working to get weight-loss drugs approved for children as young as 6, Bloomberg reported Oct. 20.

CVS is voluntarily pulling from its shelves some common decongestants that contain an active ingredient FDA advisors have deemed ineffective at relieving congestion. 

Pharmacy leaders have already cracked the code of hospital C-suites, but increasingly, they're entering executive positions across health systems. 

A California health system has noted an "exponential" increase in patients using Wegovy, Mounjaro and other similar drugs for weight loss, according to a first-of-its-kind study.